Undoubtedly, technology is one such thing that must hit the medical field first. Health is indeed the most valued asset that feeds the generations of civilization. Studying various diseases and its chromosome is one of the most essential aspects of delivering precise treatment. Next-Generation sequencing is one such thing that has made exploring the geology of diseases easier. Knowing a few facts about Genese2Me revolutionizing the medical field with Next Generation Sequencing Clinical Assays will help you in the long run.
An Overview of Next Generation Sequencing
Next-generation sequencing (NGS) is a high-throughput DNA sequencing technology that has revolutionized the field of genomics and has numerous applications in the medical field. NGS enables the rapid sequencing of millions to billions of DNA molecules simultaneously, allowing researchers and clinicians to analyze genomic data at an unprecedented scale and speed. There are a few features that you will need to know about this sequencing, such as
- The panels that Genese2Me uses are Hybridization probes that can capture the genetic mutations in a tube.
- The advanced capturing technology can pool up as many as four individual patients and their samples without bothering the testing.
- The panels that are used come with sheer uniformity while providing testing results.
- The Bioinformatics pipeline can identify low-frequency samples.
A few types of sequencing panels
The panels that Genes2Me provides come with a whole range of dedicated possibilities for testing. There are more than you can expect with the Next Generation Sequencing other than issues detecting like cardiovascular, respiratory, stomach, and neurological disorders. However, you need to know that not always the same sequencing panels are used to detect various results. Knowing a few panels that FDA approves for fast and perfect sequencing will help you opt for the apt thing you need.
The whole Exome sequencing panel
The Whole Exome Sequencing Panel – WES is usually used for detecting variants in protein-coding regions, even at times exomes. The Whole Exome Sequencing covers 95% of the exons with almost 85% of disease-causing mutations. Genes2Me ensures a comprehensive solution that covers a wide range of WES panels available in the market. The panel comes with a size of about 37.1Mb, designed to make no compromise in detecting the most accurate result.
